MariMed director acquires 75K shares via RSUs

MariMed Inc. director Edward J. Gildea exercised restricted stock units into common shares.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

MariMed Inc. director Edward J. Gildea exercised restricted stock units into common shares. On June 12, 2026, 75,000 RSUs converted into 75,000 shares of common stock on a one-for-one basis at no cash exercise price. This exhausted the June 12, 2025 RSU grant, and Gildea now holds 980,208 common shares directly.

Insider Trade Summary

75,000 shares exercised/converted

Exercise 2 txns

Insider Gildea Edward J

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	75,000	$0.00	$0.00
Exercise	Common stock	75,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (RSU) — 0 contracts (Direct); Common stock — 980,208 shares (Direct)

Footnotes (2)

F1. RSUs convert to shares of common stock on a one-for-one basis.
F2. The RSUs were granted on June 12, 2025; there are no RSUs remaining under this grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 75,000 units Shares acquired from RSUs: 75,000 shares Holdings after transaction: 980,208 shares +2 more

5 metrics

RSUs exercised 75,000 units RSUs converted to common stock on June 12, 2026

Shares acquired from RSUs 75,000 shares Common stock received from RSU conversion, one-for-one basis

Holdings after transaction 980,208 shares Common stock directly owned by Edward J. Gildea after exercise

Exercise price per RSU $0.0000 per share Reported transaction price for RSU conversion

RSU grant date June 12, 2025 Original grant date of the 75,000 RSUs

Key Terms

Restricted Stock Units (RSU), Exercise or conversion of derivative security, Common stock, derivative security

4 terms

Restricted Stock Units (RSU) financial

"security_title: "Restricted Stock Units (RSU)""

Exercise or conversion of derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

Common stock financial

"security_title: "Common stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

derivative security financial

"transaction_action: "derivative exercise/conversion""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MariMed (MRMD) report for Edward J. Gildea?

MariMed reported that director Edward J. Gildea exercised 75,000 restricted stock units into 75,000 common shares. The RSUs converted on a one-for-one basis and reflect a compensation-related equity award rather than an open-market purchase or sale.

How many MariMed (MRMD) shares does Edward J. Gildea hold after this Form 4?

After the RSU conversion, Edward J. Gildea holds 980,208 shares of MariMed common stock directly. This figure reflects his position following the June 12, 2026 exercise of 75,000 restricted stock units granted under a prior equity award.

What happened to Edward J. Gildea’s MariMed RSU grant reported in this filing?

The RSU grant reported was fully converted into common stock. All 75,000 RSUs granted on June 12, 2025 were exercised on June 12, 2026, leaving no remaining RSUs under that specific award agreement between MariMed and Edward J. Gildea.

Was there any open-market buying or selling by Edward J. Gildea in this MariMed Form 4?

The Form 4 shows no open-market buying or selling. It reports the exercise of 75,000 restricted stock units into common shares, an equity compensation event described as an exercise or conversion of a derivative security at zero exercise price.

How do the MariMed RSUs convert to common stock in this Form 4?

The restricted stock units convert to common stock on a one-for-one basis. In this filing, 75,000 RSUs became 75,000 common shares of MariMed, consistent with footnote disclosure explaining the conversion terms tied to this equity award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/12/2026 - 04:45 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gildea Edward J

(Last)

(First)

(Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD

MASSACHUSETTS

02062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	06/12/2026		M		75,000	A	$0⁽¹⁾	980,208	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSU)	⁽¹⁾	06/12/2026		M			75,000	⁽²⁾	⁽²⁾	Common Stock, par value $.001 per share	75,000	$0	0	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. The RSUs were granted on June 12, 2025; there are no RSUs remaining under this grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Edward Gildea	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR